|
|
A Nomura, K Nishikawa, Y Yuzawa, H Okada, N Okada, B P Morgan, S J Piddlesden, M Nadai, T Hasegawa, S Matsuo
J Clin Invest. 1995;
96(5):2348
doi:10.1172/JCI118291
Abstract |
Full text
| PDF

T
he kidney widely expresses membrane-associated complement regulatory proteins (membrane inhibitors of complement). The aim of this work was to evaluate the roles of these molecules in rat kidneys in vivo. To suppress functions of rat membrane inhibitors of complement, two mAbs, 512 and 6D1, were used. 5I2 and 6D1 inhibit functions of membrane inhibitors of complement at C3 level (rat Crry/p65) and C8/9 level (rat CD59), respectively. F(ab')2 fragment of 5I2 or 6D1 was perfused in the left kidneys, and perfusate was discarded from the renal vein. After perfusion, the left kidneys were connected to systemic circulation. In rats perfused with 5I2, mouse IgG was found in glomeruli, peritubular capillaries, vascular bundles, and tubules 15 min after recirculation. Binding of C3 and C5b-9 was evident in these areas. 1 d after perfusion with 5I2, cast formation, dilatation of tubular lumen, and tubular cell degeneration were observed. At day 4 through day 7, significant mononuclear cell infiltration and proximal tubule damage were observed. These changes were completely prevented by complement depletion. Rats perfused with 6D1 showed the binding of mouse IgG in the similar areas as 5I2, but C3 or C5b-9 deposition was not observed. Rats perfused with 6D1 or vehicle only did not show any pathology in the left kidneys. These results suggest that rat Crry/p65 plays protective roles against spontaneously occurring indiscriminate attack to tubulointerstitial tissues by autologous complement and that rat Crry/p65 is one of the important factors to maintain normal integrity of the kidney in rats.
Citation information
This citation data is accumulated from CrossRef, which receives citation information from participating publishers, including this journal.
Not all publishers participate in CrossRef, so this information is not comprehensive.
Additionally, data may not reflect the most current citations to this article,
and the data may differ from citation information available from other sources
(for example, Google Scholar, Web of Science, and Scopus).
Total citations by year
in CrossRef
Citations to this article
in CrossRef
(24)
| Title and authors |
Publication |
Year |
Distinct roles for C3a and C5a in complement-induced tubulointerstitial injury
Lihua Bao, Ying Wang, Mark Haas, Richard J Quigg
|
Kidney Int
|
2011 |
Dynamic control of the complement system by modulated expression of regulatory proteins.
Joshua M Thurman, Brandon Renner
|
Lab. Invest.
|
2011 |
Basigin/CD147 Promotes Renal Fibrosis after Unilateral Ureteral Obstruction
Noritoshi Kato, Tomoki Kosugi, Waichi Sato, Takuji Ishimoto, Hiroshi Kojima, Yuka Sato, Kazuma Sakamoto, Shoichi Maruyama, Yukio Yuzawa, Seiichi Matsuo, Kenji Kadomatsu
|
The American Journal of Pathology
|
2011 |
Specific collaboration between rat membrane complement regulators Crry and CD59 protects peritoneum from damage by autologous complement activation
T. Mizuno, M. Mizuno, B. P. Morgan, Y. Noda, K. Yamada, N. Okada, Y. Yuzawa, S. Matsuo, Y. Ito
|
Nephrology Dialysis Transplantation
|
2010 |
Mapping quantitative trait loci for proteinuria-induced renal collagen deposition
N Kato, Y Watanabe, Y Ohno, T Inoue, Y Kanno, H Suzuki, H Okada
|
Kidney Int
|
2008 |
The Many Effects of Complement C3- and C5-Binding Proteins in Renal Injury
Tipu S. Puri, Richard J. Quigg
|
Seminars in Nephrology
|
2007 |
Midkine antisense oligodeoxyribonucleotide inhibits renal damage induced by ischemic reperfusion
Waichi Sato, Yoshifumi Takei, Yukio Yuzawa, Seiichi Matsuo, Kenji Kadomatsu, Takashi Muramatsu
|
Kidney Int
|
2005 |
Overexpression of complement inhibitor Crry does not prevent cryoglobulin-associated membranoproliferative glomerulonephritis
Anja S. Muhlfeld, Stephan Segerer, Kelly Hudkins, Andrew G. Farr, Lihua Bao, Damian Kraus, V. Michael Holers, Richard J. Quigg, Charles E. Alpers
|
Kidney Int
|
2004 |
Lack of the growth factor midkine enhances survival against cisplatin-induced renal damage.
Hanayo Kawai, Waichi Sato, Yukio Yuzawa, Tomoki Kosugi, Seiichi Matsuo, Yoshifumi Takei, Kenji Kadomatsu, Takashi Muramatsu
|
The American Journal of Pathology
|
2004 |
Decay-Accelerating Factor Confers Protection Against Complement-Mediated Podocyte Injury in Acute Nephrotoxic Nephritis
Feng Lin, Steven N. Emancipator, David J. Salant, M. Edward Medof
|
Lab Invest
|
2002 |
|